Zacks Investment Research
12 Jun 2026, 22:50 UTC · 2h ago
Abbott (ABT) Stock Declines While Market Improves: Some Information for Investors
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

Zacks Investment Research
12 Jun 2026, 22:50 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

What the story claims
4 claims · each scored for market impact
Abbott (ABT) currently holds a Zacks Rank of #4 (Sell). — A 'Sell' rating from a quantitative ranking system generally signals a negative outlook for near-term price performance.
-0.40Abbott is projected to report quarterly net sales of $12.53 billion, a 12.43% increase from the prior-year period. — Strong double-digit projected revenue growth is a positive fundamental indicator for the company.
+0.30Abbott's forward P/E ratio of 16.36 is at a discount compared to its industry average of 17.46. — A lower valuation relative to peers can suggest the stock is undervalued, potentially attracting value investors.
+0.20The Zacks Consensus Estimate for Abbott's quarterly EPS is $1.28, representing a 1.59% increase year-over-year. — Slight growth in earnings per share is positive, though the low growth rate limits the impact.
Continue reading
6 related stories
Top 2 movers · tap to explore
Which stocks this story touches
The company currently holds a Zacks Rank of #4 (Sell) and its recent trading session ended lower than the S&P 500.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works

Zacks Investment Research
2h ago